专利号:US-12054512-B2 优先权日:2017-11-10 标 题 :Sting modulator compounds, and methods of making and using 发明人:VYSKOCIL STEPAN; CIAVARRI JEFFREY; CULLIS COURTNEY; ENGLAND DYLAN BRADLEY; GOULD ALEXANDRA E; GREENSPAN PAUL; HU YONGBO; LANGSTON STEVEN; LI GANG; MIZUTANI HIROTAKE; OKANIWA MASANORI 权利人:TAKEDA PHARMACEUTICALS CO 摘要:The present disclosure provides STING modulators/agonists, and methods of synthesis and methods for using for the prophylaxis or treatment of cancer and other STING-related diseases.The present disclosure relates to a compound represented by the Formula (I):wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.
专利号:US-9023384-B2 优先权日:2004-11-02 标题:Liposome and method for injecting substance to cell using this liposome 发明人:MORITA IKUO; AKIYOSHI KAZUNARI; NOMURA SHINICHIRO 权利人:MORITA IKUO; AKIYOSHI KAZUNARI; NOMURA SHINICHIRO; UNIV TOKYO MEDICAL & DENTAL; DAINIPPON PRINTING CO LTD 摘要:It is intended to efficiently inject into a target cell, a substance charged within a liposome. The present inventors have found that connexin synthesized within a liposome is introduced as connexon having a gap junction function into the liposome membrane. Specifically, the liposome according to the present invention is a liposome in which connexon composed of connexin synthesized by an in-vitro protein synthesis system is incorporated in a state of having a gap junction function.
专利号:RU-2085557-C1 优先权日:1991-09-30 标 题:Pyrimidine nucleoside derivatives or their pharmaceutically acceptable salts and method of their synthesis
专利号:US-8791263-B2 优先权日:2010-09-17 标 题 :Cortistatin A analog and use thereof 发明人:KOBAYASHI MOTOMASA; KOTOKU NAOYUKI; ARAI MASAYOSHI; TAMURA SATORU 权利人:KOBAYASHI MOTOMASA; KOTOKU NAOYUKI; ARAI MASAYOSHI; TAMURA SATORU; UNIV OSAKA 摘要:A compound represented by the general formula (M): n n n n n n n n n n n n (wherein R 1 represents a substituted or unsubstituted aromatic heterocyclic group, n R 2 represents a hydrogen atom, a substituted or unsubstituted alkyl group having 1 to 3 carbon atoms, OR 3 , N(R 3 ) 2 , C(â•?O)OR 3 or C(â•?O)N(R 3 ) 2 , n R 3 represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or an acyl group having 1 to 4 carbon atoms, n R 4 represents a hydrogen atom, an oxygen atom or OR 5 , and n R 5 represents a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, or an acyl group having 1 to 3 carbon atoms); or n a pharmaceutically acceptable salt thereof is a cortistatin A analog which is useful as an active ingredient of medicaments for cancer prevention or treatment in that the analog can be mass-produced by chemical synthesis due to its simple chemical structure and retains the same biological activities as those of cortistatin A.
专利号:CN-104031048-B 优先权日:2014-05-28 标题 :A kind of β-chloroethylnitrosourea compound and its synthesis method and application
专利号:RU-2116306-C1 优先权日:1990-06-15 标 题:Pyrimidine nucleosides, methods of synthesis, pharmaceutical composition
摘要:Current Chemotherapy, Proceedings of the 10th International Congress of Chemotherapy, Zurich 1977, Siegenthaler, W., and R. Luethy, eds., 2 vols., Washington, DC, American Soc. for Microbiology, 1978, 2(1233), 1978 参考文献:10.1007/bf02478921 摘要:Wakabayashi T, Yoshida J, Mizuno M, Kajita Y. Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma. Brain Tumor Pathol. 2001;18(1):23–8. doi: 10.1007/bf02478921. 参考文献:10.1007/bf00177440 摘要:Zenke K, Nakagawa K, Kumon Y, Ohta S, Hatakeyama T, Sakaki S. A strategy for selective anti-cancer drug concentration increase in rat glioma tissue with Ca(2+)-channel blocker co-administration: calcium kinetics in intra-glioma arteriolar smooth muscle cells. J Neurooncol. 1996 Oct;30(1):25–36. doi: 10.1007/bf00177440. 参考文献:10.1007/s00381-011-1485-y 摘要:Saito R, Kumabe T, Sonoda Y, Kanamori M, Yamashita Y, Watanabe M, Tominaga T. Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma. Childs Nerv Syst. 2011 Sep;27(9):1399–406. doi: 10.1007/s00381-011-1485-y. 参考文献:10.1007/s00701-020-04514-3 摘要:Ono T, Reinhardt A, Takahashi M, Nanjo H, Kamataki A, von Deimling A, Shimizu H. Comparative molecular analysis of primary and recurrent oligodendroglioma that acquired imbalanced 1p/19q codeletion and TP53 mutation: a case report. Acta Neurochir (Wien). 2020 Dec;162(12):3019–24. doi: 10.1007/s00701-020-04514-3.